Novartis Restructuring Continues as Pharmaceuticals Division Splits, along with Pharma CEO

SUGAR LAND--May 27, 2015--Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--One of the Pharmaceutical-Biotech Industry's top three drug makers, Swiss-based Novartis International AG (NYSE:NVS) (Basel, has restructured its pharmaceuticals division by creating two business units--Novartis Pharmaceuticals and Novartis Oncology. Coinciding with the organizational split, the division head and chief executive officer of the company's Pharmaceuticals division, David Epstein, called it quits.